Windlas Biotech Limited has announced the grant of 5,70,500 stock options/units to eligible employees, as approved by the Nomination and Remuneration Committee of the Board of Directors on September 15, 2025.
Each unit, upon exercise, entitles the holder to the allotment of one fully paid-up equity share with a face value of ₹5 of the Company.
The grant is in accordance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
The effective grant date is September 15, 2025.
The said Units shall be granted at a price of ₹5 i.e at face value of equity share of the Company.
Subject to fulfilling conditions specified in the Plan, vested Units can be exercised within a period of four years from the date of vesting.
Subject to fulfilling conditions specified in the above said Plan and the Grant Letters in respect of the "Restricted Stock Units" ("RSUs") or "Performance Stock Units" ("PSUs”), the Units granted shall vest in four equal instalments of 25% each on the expiry of 12, 24, 36 and 48 months respectively from the effective date of grant of Units.
The said Units shall be granted at a price of ₹5 i.e at face value of equity share of the Company.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
